More Articles

Profits for generics’ giant Teva soar Generics/News | Posted 31/01/2011

Israel-based generics’ giant Teva Pharmaceutical Industries has reported a third quarter 2010 profit rise of 47%, mainly attributed to sales of its multiple sclerosis drug Copaxone (glatiramer acet...

The generic drug wars: deeply discounted medication Generics/Research | Posted 31/01/2011

Fierce competition among major pharmacy chains in the US, such as CVS, Walgreens and Walmart, has led to a generic prescription pricing war with unclear public health implications.

Ranbaxy gets 180-day exclusivity for Alzheimer’s generic Generics/News | Posted 31/01/2011

On 30 November 2010, generics’ giant and India’s largest pharmaceutical manufacturer, Ranbaxy Laboratories, announced the launch of a generic version of Pfizer’s blockbuster Alzheimer’s treatment,...

Sandoz announces biosimilar rituximab Biosimilars/News | Posted 21/01/2011

Sandoz, the generic drug division of Swiss drug giant Novartis AG, announced on 10 January 2011 a phase II clinical trial for a biosimilar version of leading monoclonal antibody rituximab.

The clinical equivalence of brand-name beta-blockers and their generic counterparts Generics/Research | Posted 21/01/2011

The healthcare systems of the world are all under pressure to reduce costs and using generic substitution for the initially prescribed, more expensive equivalents is an obvious area to investigate....

Are generic diuretics clinically equivalent to their brand-name counterparts for the management of cardiovascular disease? Generics/Research | Posted 21/01/2011

Prescription costs are rising, mainly due to brand-name drugs recouping their investment during the period of patent protection and market exclusivity. For this reason, many payers and prescribers...

Cost of new drug challenged Pharma News | Posted 21/01/2011

An editorial in the New England Journal of Medicine (NEJM) issue of 23 September 2010 took the unusual position of challenging a study published in the same issue.

Sun gains tentative approval for generic Crestor Generics/News | Posted 21/01/2011

Indian-based Sun Pharmaceutical Industries announced on 29 September 2010 that the FDA had granted its subsidiary a tentative approval for its Abbreviated New Drug Application (ANDA) to market a ge...